The Nanoscope Instruments team just wrapped up a productive meeting at the 2023 Association for Research and Vision in Ophthalmology (ARVO) in New Orleans last Thursday. It was great to see previous customers, acquaintances, and make new friends as well. The instruments team fielded several requests from
Read more →With sixty days until the start of 2023 it is a great time for researchers, whether in academia or in corporate settings, to evaluate our ocular instruments. Additional instrument information is here > https://tinyurl.com/mryam873. We welcome the opportunity to demo our products to you. Please register here
Read more →
Good things come in 3’s! Nanoscope receives award (again) as part of the top research team in NEI 3-D ROC challenge Arlington, TX, September 20, 2022—Researchers at the University of Colorado led by Valeria Canto-Soler and those from Nanoscope® led by Samarendra Mohanty, PhD were recognized as
Read more →Nanoscope Therapeutics Appoints Pharma Industry Veteran Aaron Osborne, MBBS, as Chief Medical Officer and Chief Development Officer DALLAS, April 18, 2022 — Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal diseases, today announced Aaron Osborne, MBBS, was appointed Chief Medical Officer and Chief Development Officer.
Read more →